October 18, 2026
HEOR
Latest News and Insights
October 18, 2026
October 11, 2026
HEOR
Comparative Effectiveness Evidence for the Medicare Population: Building the Section I Case When the Trials Enrolled Younger Patients
Read more →
October 11, 2026
HEOR
Therapeutic Alternatives in Medicare Drug Price Negotiation: How CMS Identifies Them and How a Manufacturer Makes Its Case
Read more →
October 4, 2026
HEOR
Launch Prices After the IRA: What the JAMA Data Mean for Medicare Negotiation Evidence and US Dossiers
Read more →
October 4, 2026
HEOR
Budget Impact Analysis for India and the Gulf: Methods, Payer Requirements and Model Design
Read more →
October 4, 2026
HEOR
From NMA to Economic Model: Turning Relative Treatment Effects Into Cost-Effectiveness Model Inputs
Read more →
September 27, 2026
HEOR
NMA Feasibility Assessment: How to Decide Whether a Network Meta-Analysis Can Answer the Question
Read more →
September 27, 2026
HEOR
NMA, ITC, MAIC, STC or ML-NMR: Choosing the Indirect Comparison Method for an HTA Submission
Read more →
September 20, 2026
Market Access
CMS ICR Section I: Evidence About Alternative Treatments in Medicare Drug Price Negotiation
Read more →
September 14, 2026
Market Access
Medicare Drug Price Negotiation: Manufacturer Evidence, Negotiation Data Elements and How to Prepare
Read more →
September 13, 2026
September 11, 2026
September 10, 2026
Regulatory Affairs
Biosimilars in 2026: The Global Landscape and the EvySaif Biosimilar Atlas, a Global Biosimilar Intelligence Platform
Read more →
September 6, 2026
Regulatory Affairs
Biosimilar Development in 2026: Regulatory Requirements, Evidence Planning and Market Access
Read more →
September 5, 2026
Medical Writing
Clinical Study Report (CSR): ICH E3 Structure, Content and the Writing Process
Read more →
September 4, 2026
HEOR
Network Meta-Analysis: A Practical Guide to Methods, Assumptions, Clinical Evidence and HTA Applications
Read more →
September 4, 2026
Regulatory Affairs
Drug Registration in UAE: The EDE Approval Process, Requirements, Pathways and Timelines
Read more →
September 2, 2026
Regulatory Affairs
CDSCO New Drug Approval in India: Process, Requirements, Documents and Timeline
Read more →
September 1, 2026
Regulatory Affairs
Drug Registration in India: CDSCO Approval Process, Requirements & Regulatory Strategy
Read more →
August 31, 2026
August 30, 2026
Regulatory Affairs
CDSCO Medical Device Regulations: The 2026 Guide to Classification, Licensing, and Market Entry in India
Read more →
August 23, 2026
Regulatory Affairs
The AYUSH Product Development Roadmap: From Classification to License in India
Read more →
August 23, 2026
Regulatory Affairs
CDSCO Import License for Medical Devices in India: MD-14, MD-15 and the Full Pathway
Read more →
August 19, 2026
Clinical Pharmacology
Pharmacokinetics and Pharmacodynamics: The Complete Guide to PK/PD Parameters, Studies, and What Regulators Expect
Read more →
August 13, 2026
August 13, 2026
August 13, 2026
Digital Health
CDSCO's Final Medical Device Software Guidance: What It Says and What You Must Do
Read more →
August 13, 2026
Regulatory Affairs
Registering a New Medical Device in India with No Predicate: The Complete CDSCO Tutorial
Read more →
August 13, 2026
August 13, 2026
September 10, 2025
September 10, 2025
July 18, 2026
July 18, 2026
Regulatory Affairs
CDSCO Medical Device Registration in India: Classification, Licenses, and Timelines
Read more →
July 18, 2026